{"zip": "46285", "sector": "Healthcare", "fullTimeEmployees": 34690, "longBusinessSummary": "Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; and Junshi Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.", "city": "Indianapolis", "phone": "317 276 2000", "state": "IN", "country": "United States", "companyOfficers": [], "website": "http://www.lilly.com", "maxAge": 1, "address1": "Lilly Corporate Center", "industry": "Drug Manufacturers\u2014General", "previousClose": 198.42, "regularMarketOpen": 199.01, "twoHundredDayAverage": 184.50192, "trailingAnnualDividendYield": 0.0154722305, "payoutRatio": 0.4596, "volume24Hr": null, "regularMarketDayHigh": 200.92, "navPrice": null, "averageDailyVolume10Day": 3780300, "totalAssets": null, "regularMarketPreviousClose": 198.42, "fiftyDayAverage": 192.20177, "trailingAnnualDividendRate": 3.07, "open": 199.01, "averageVolume10days": 3780300, "expireDate": null, "yield": null, "algorithm": null, "dividendRate": 3.4, "exDividendDate": 1613001600, "beta": 0.261996, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 198.25, "priceHint": 2, "currency": "USD", "trailingPE": 29.809881, "regularMarketVolume": 1973194, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 191061655552, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 3423730, "priceToSalesTrailing12Months": 7.496847, "dayLow": 198.25, "ask": 0, "ytdReturn": null, "askSize": 1000, "volume": 1973194, "fiftyTwoWeekHigh": 218, "forwardPE": 22.994226, "fromCurrency": null, "fiveYearAvgDividendYield": 2.22, "fiftyTwoWeekLow": 129.21, "bid": 0, "tradeable": false, "dividendYield": 0.018099999, "bidSize": 800, "dayHigh": 200.92, "exchange": "NYQ", "shortName": "Eli Lilly and Company", "longName": "Eli Lilly and Company", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "isEsgPopulated": true, "gmtOffSetMilliseconds": "-14400000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "LLY", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_285467", "uuid": "7b37be39-dfde-3602-b0e4-4d76cf52143b", "market": "us_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 7.24, "beta3Year": null, "profitMargins": 0.23906, "enterpriseToEbitda": 21.722, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": 8.66, "revenueQuarterlyGrowth": null, "sharesOutstanding": 959481984, "fundInceptionDate": null, "annualReportExpenseRatio": null, "bookValue": 7.589, "sharesShort": 6376547, "sharesPercentSharesOut": 0.0066000004, "fundFamily": null, "lastFiscalYearEnd": 1609372800, "heldPercentInstitutions": 0.83259004, "netIncomeToCommon": 6092499968, "trailingEps": 6.68, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 26.239294, "heldPercentInsiders": 0.00148, "nextFiscalYearEnd": 1672444800, "mostRecentQuarter": 1617148800, "shortRatio": 1.72, "sharesShortPreviousMonthDate": 1615766400, "floatShares": 857165544, "enterpriseValue": 184510889984, "threeYearAverageReturn": null, "lastSplitDate": 876960000, "lastSplitFactor": "2:1", "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": -0.069, "dateShortInterest": 1618444800, "pegRatio": 1.87, "lastCapGain": null, "shortPercentOfFloat": 0.008, "sharesShortPriorMonth": 6978695, "category": null, "fiveYearAverageReturn": null, "regularMarketPrice": 199.01, "logo_url": "https://logo.clearbit.com/lilly.com"}